Versatile Oral Insulin Delivery Nanosystems: From Materials to Nanostructures.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

Original Publication: Basel, Switzerland : MDPI, [2000-

Diabetes Mellitus*/drug therapy ; Nanostructures*; Administration, Oral ; Blood Glucose ; Drug Delivery Systems ; Humans ; Insulin/therapeutic use ; Insulin, Regular, Human/therapeutic use ; Pharmaceutical Preparations

Diabetes is a chronic metabolic disease characterized by lack of insulin in the body leading to failure of blood glucose regulation. Diabetes patients usually need frequent insulin injections to maintain normal blood glucose levels, which is a painful administration manner. Long-term drug injection brings great physical and psychological burden to diabetic patients. In order to improve the adaptability of patients to use insulin and reduce the pain caused by injection, the development of oral insulin formulations is currently a hot and difficult topic in the field of medicine and pharmacy. Thus, oral insulin delivery is a promising and convenient administration method to relieve the patients. However, insulin as a peptide drug is prone to be degraded by digestive enzymes. In addition, insulin has strong hydrophilicity and large molecular weight and extremely low oral bioavailability. To solve these problems in clinical practice, the oral insulin delivery nanosystems were designed and constructed by rational combination of various nanomaterials and nanotechnology. Such oral nanosystems have the advantages of strong adaptability, small size, convenient processing, long-lasting pharmaceutical activity, and drug controlled-release, so it can effectively improve the oral bioavailability and efficacy of insulin. This review summarizes the basic principles and recent progress in oral delivery nanosystems for insulin, including physiological absorption barrier of oral insulin and the development of materials to nanostructures for oral insulin delivery nanosystems.

J Control Release. 2006 Aug 28;114(2):242-50. (PMID: 16859800)
Nat Biotechnol. 2021 Oct;39(10):1172-1174. (PMID: 34621072)
ACS Appl Mater Interfaces. 2018 Mar 28;10(12):9916-9928. (PMID: 29504398)
Mater Sci Eng C Mater Biol Appl. 2017 Jan 1;70(Pt 1):278-286. (PMID: 27770892)
Pharmaceutics. 2019 Jun 26;11(7):. (PMID: 31248025)
J Pharm Sci. 2018 Aug;107(8):2136-2143. (PMID: 29689252)
PLoS One. 2013 Apr 09;8(4):e59524. (PMID: 23593142)
J Pharm Sci. 1997 Apr;86(4):430-3. (PMID: 9109043)
Drug Dev Ind Pharm. 2017 Nov;43(11):1892-1898. (PMID: 28689439)
Sci Rep. 2016 May 26;6:26789. (PMID: 27226415)
J Agric Food Chem. 2018 Nov 7;66(44):11784-11796. (PMID: 30346766)
J Pharm Sci. 1996 Oct;85(10):1128-30. (PMID: 8897284)
Am J Physiol Endocrinol Metab. 2006 Jan;290(1):E1-E8. (PMID: 16339923)
Int J Pharm. 2015 Apr 30;484(1-2):181-91. (PMID: 25724135)
Int J Pharm. 2013 Apr 15;447(1-2):75-93. (PMID: 23428883)
Angew Chem Int Ed Engl. 2001 Nov 19;40(22):4128-4158. (PMID: 29712109)
Expert Opin Drug Deliv. 2014 Aug;11(8):1323-35. (PMID: 24816134)
Curr Pharm Des. 2017;23(11):1575-1588. (PMID: 28120725)
Biomaterials. 2017 Dec;147:145-154. (PMID: 28946130)
Annu Rev Pharmacol Toxicol. 1991;31:457-67. (PMID: 2064382)
Int J Pharm. 1999 Jun 25;183(2):125-32. (PMID: 10361163)
ACS Macro Lett. 2020 Mar 17;9(3):426-430. (PMID: 35648547)
Sci Rep. 2021 Oct 12;11(1):20191. (PMID: 34642409)
Acc Chem Res. 2012 Apr 17;45(4):619-29. (PMID: 22236133)
Biomacromolecules. 2019 Jan 14;20(1):528-538. (PMID: 30537806)
Biomaterials. 2011 Sep;32(26):6164-73. (PMID: 21641031)
J Am Chem Soc. 2018 May 2;140(17):5678-5681. (PMID: 29641892)
J Control Release. 2017 Oct 10;263:4-17. (PMID: 28235590)
Ann Intern Med. 1990 Dec 15;113(12):909-15. (PMID: 2240915)
Lancet. 2018 Jun 16;391(10138):2392-2393. (PMID: 29784147)
Colloids Surf B Biointerfaces. 2019 Nov 1;183:110443. (PMID: 31445358)
J Colloid Interface Sci. 2020 Feb 15;560:690-700. (PMID: 31706652)
Diabetes Care. 2002 Mar;25(3):593-8. (PMID: 11874953)
Nanoscale. 2021 Mar 21;13(11):5679-5692. (PMID: 33595040)
ACS Appl Mater Interfaces. 2015 Jul 22;7(28):15430-41. (PMID: 26111015)
ACS Appl Mater Interfaces. 2017 Aug 16;9(32):26648-26664. (PMID: 28741923)
Proc Natl Acad Sci U S A. 2018 Jul 10;115(28):7296-7301. (PMID: 29941553)
ACS Appl Mater Interfaces. 2020 May 20;12(20):22581-22592. (PMID: 32340452)
Biomater Sci. 2020 Jun 21;8(12):3270-3277. (PMID: 32490443)
J Agric Food Chem. 2017 Oct 11;65(40):8866-8874. (PMID: 28925252)
Cleve Clin J Med. 2011 May;78(5):332-42. (PMID: 21536829)
Res Pharm Sci. 2017 Oct;12(5):346-352. (PMID: 28974972)
Biomacromolecules. 2018 Jun 11;19(6):2123-2136. (PMID: 29664632)
ACS Appl Mater Interfaces. 2018 May 2;10(17):14281-14286. (PMID: 29664280)
Int J Pharm. 2000 Sep 15;205(1-2):127-34. (PMID: 11000549)
Adv Drug Deliv Rev. 2018 Jan 15;124:82-97. (PMID: 29106910)
Adv Healthc Mater. 2019 Jun;8(12):e1801123. (PMID: 30485708)
Nanomaterials (Basel). 2021 Jul 06;11(7):. (PMID: 34361144)
Nat Nanotechnol. 2020 Jul;15(7):605-614. (PMID: 32483319)
Trends Immunol. 2018 Sep;39(9):677-696. (PMID: 29716793)
Mater Sci Eng C Mater Biol Appl. 2016 Dec 1;69:37-45. (PMID: 27612686)
Int J Pharm. 1999 Aug 5;185(1):73-82. (PMID: 10425367)
Drug Discov Today. 2016 May;21(5):856-63. (PMID: 27094490)
Int J Pharm. 2016 Sep 10;511(1):462-472. (PMID: 27418563)
J Drug Target. 2005 Dec;13(10):563-72. (PMID: 16390817)
Am J Clin Dermatol. 2003;4(10):661-7. (PMID: 14507228)
Int J Biol Macromol. 2020 May 1;150:281-288. (PMID: 32057846)
ACS Nano. 2016 Oct 25;10(10):9216-9226. (PMID: 27723299)
BioDrugs. 2005;19(3):165-77. (PMID: 15984901)
Nature. 2003 May 29;423(6939):550-5. (PMID: 12754525)
J Agric Food Chem. 2018 Oct 10;66(40):10479-10489. (PMID: 30240201)
PLoS One. 2014 Jan 06;9(1):e84651. (PMID: 24400106)
J Pharm Sci. 2019 Oct;108(10):3408-3415. (PMID: 31176647)
J Mater Chem B. 2018 Dec 7;6(45):7451-7461. (PMID: 32254747)
Mater Sci Eng C Mater Biol Appl. 2017 Sep 1;78:420-428. (PMID: 28576004)
Nature. 2014 May 29;509(7502):S58-9. (PMID: 24870822)
ACS Appl Mater Interfaces. 2020 Nov 4;12(44):49431-49441. (PMID: 33089977)
Biochim Biophys Acta. 1980 Dec 5;620(3):400-9. (PMID: 7016185)
J Control Release. 2018 Jan 10;269:159-170. (PMID: 29129657)
Pharm Sci Technol Today. 1999 Apr;4(2):144-151. (PMID: 10322371)
Mol Pharm. 2013 May 6;10(5):1644-54. (PMID: 23331253)
Colloids Surf B Biointerfaces. 2020 Oct;194:111203. (PMID: 32585538)
Nat Biomed Eng. 2020 Jan;4(1):84-96. (PMID: 31686002)
J Pharm Sci. 2000 Jul;89(7):951-7. (PMID: 10861597)
Biomacromolecules. 2014 Jan 13;15(1):350-60. (PMID: 24283460)
Sci Transl Med. 2013 Nov 27;5(213):213ra167. (PMID: 24285486)
Am J Physiol. 1984 Feb;246(2 Pt 1):E174-80. (PMID: 6364842)
Nanoscale. 2014 Jan 21;6(2):825-32. (PMID: 24264141)
Carbohydr Polym. 2020 Feb 1;229:115506. (PMID: 31826394)
N Engl J Med. 2009 Apr 16;360(16):1646-54. (PMID: 19369670)
ACS Nano. 2011 Feb 22;5(2):1385-94. (PMID: 21268592)
ACS Nano. 2018 Oct 23;12(10):9830-9841. (PMID: 30253648)
Acta Pharm Sin B. 2018 Jan;8(1):97-105. (PMID: 29872626)
J Control Release. 2007 Sep 11;122(1):94-101. (PMID: 17651854)
Mol Pharm. 2018 Oct 1;15(10):4756-4763. (PMID: 30125508)
J Pharm Pharmacol. 2010 May;62(5):583-91. (PMID: 20609059)
J Control Release. 2016 Jun 28;232:29-41. (PMID: 27074369)
Macromol Biosci. 2019 Sep;19(9):e1900148. (PMID: 31361066)
Drug Deliv. 2016;23(2):429-36. (PMID: 24901208)
ACS Appl Mater Interfaces. 2018 Mar 21;10(11):9315-9324. (PMID: 29484890)
Biomater Sci. 2019 Mar 26;7(4):1493-1506. (PMID: 30672923)
ACS Nano. 2009 Jan 27;3(1):16-20. (PMID: 19206243)
Dig Dis Sci. 2007 Jan;52(1):1-17. (PMID: 17205399)
Mol Pharm. 2020 Jan 6;17(1):239-250. (PMID: 31800258)
Front Immunol. 2018 Feb 05;9:155. (PMID: 29459867)
ACS Nano. 2011 Dec 27;5(12):9977-83. (PMID: 22077198)
Biomater Sci. 2021 Feb 9;9(3):685-699. (PMID: 33330897)
J Pharm Sci. 2019 Sep;108(9):2994-3002. (PMID: 31047941)
J Control Release. 2007 Jul 16;120(1-2):11-7. (PMID: 17509718)
Biomaterials. 2012 Mar;33(9):2801-11. (PMID: 22243802)
Int J Biol Macromol. 2015 Jan;72:640-8. (PMID: 25239194)
Scand J Gastroenterol. 1986 Aug;21(6):669-77. (PMID: 3749803)
Biomaterials. 2018 Jan;151:13-23. (PMID: 29055774)
Carbohydr Polym. 2021 Jun 1;261:117873. (PMID: 33766360)
Nature. 1985 Feb 28-Mar 6;313(6005):756-61. (PMID: 2983222)
J Control Release. 2020 May 10;321:641-653. (PMID: 32097672)
Nano Today. 2010 Apr 1;5(2):143-159. (PMID: 20543895)
Chem Rev. 2015 Oct 14;115(19):11109-46. (PMID: 26154342)
ACS Appl Mater Interfaces. 2021 Apr 21;13(15):18077-18088. (PMID: 33830730)
Int J Nanomedicine. 2019 Nov 25;14:9127-9138. (PMID: 31819423)
J Control Release. 2019 Nov 10;313:1-13. (PMID: 31622690)
Nanomedicine. 2018 Feb;14(2):353-364. (PMID: 29157980)
ACS Omega. 2021 Jan 25;6(4):2734-2741. (PMID: 33553891)
Int J Pharm. 1999 Nov 10;190(1):35-40. (PMID: 10528094)
Immunology. 1997 Sep;92(1):69-74. (PMID: 9370926)
RSC Adv. 2020 Jul 17;10(45):26777-26791. (PMID: 35515778)
J Biol Chem. 1999 Nov 5;274(45):31751-4. (PMID: 10542193)
Nanoscale. 2018 Feb 15;10(7):3307-3319. (PMID: 29384554)
J Nanosci Nanotechnol. 2011 Mar;11(3):1823-33. (PMID: 21449317)
ACS Nano. 2015 Mar 24;9(3):2345-56. (PMID: 25658958)
Technol Health Care. 2020;28(3):325-335. (PMID: 31594273)
Nat Plants. 2017 Dec;3(12):956-964. (PMID: 29180813)
Am J Emerg Med. 1996 Jan;14(1):98-9. (PMID: 8630171)

2021YFA0716700 Ministry of Science and Technology of China

Keywords: absorption barrier; bioavailability; nanodrug delivery system; oral insulin

0 (Blood Glucose)
0 (Insulin)
0 (Insulin, Regular, Human)
0 (Pharmaceutical Preparations)

Date Created: 20220325 Date Completed: 20220408 Latest Revision: 20240825

20240826

PMC8952690

10.3390/ijms23063362

35328783